Twist Bioscience Corp. Forecast, price target & analysts
Twist Bioscience Corp. Target price 2025 - Analyst rating & recommendation
Twist Bioscience Corp. Classifications & Recommendation:
Twist Bioscience Corp. Price Target
| Target Price | $55.82 |
| Price | $38.56 |
| Potential |
44.76%
register free of charge
|
| Number of Estimates | 11 |
|
11 Analysts have issued a price target Twist Bioscience Corp. 2026 .
The average Twist Bioscience Corp. target price is $55.82.
This is
44.76%
register free of charge
$65.00
68.57%
register free of charge
$40.00
3.73%
register free of charge
|
|
| A rating was issued by 13 analysts: 10 Analysts recommend Twist Bioscience Corp. to buy, 2 to hold and 1 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the Twist Bioscience Corp. stock has an average upside potential 2026 of
44.76%
register free of charge
|
Sales and Margin forecast 2025, 2026 to 2029
| Sep '24 |
2025 Estimates |
|
|---|---|---|
| Revenue Million $ | 312.97 | 376.53 |
| 27.69% | 20.31% | |
| EBITDA Margin | -46.16% | -29.11% |
| 36.29% | 36.94% | |
| Net Margin | -68.53% | -34.15% |
| 21.68% | 50.17% |
11 Analysts have issued a sales forecast Twist Bioscience Corp. 2025 . The average Twist Bioscience Corp. sales estimate is
This results in the following potential growth metrics:
6 Analysts have issued an Twist Bioscience Corp. EBITDA forecast 2025. The average Twist Bioscience Corp. EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
5 Twist Bioscience Corp. Analysts have issued a net profit forecast 2025. The average Twist Bioscience Corp. net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Earnings per share, P/E ratio and EV/sales Estimates 2025, 2026 to 2029
| Sep '24 |
2025 Estimates |
|
|---|---|---|
| Earnings Per Share $ | -3.60 | -2.16 |
| 0.00% | 40.00% | |
| P/E | negative | |
| EV/Sales | 5.61 |
5 Analysts have issued a Twist Bioscience Corp. forecast for earnings per share. The average Twist Bioscience Corp. <a href=https://blog.stocksguide.com/knowledge/eps-simply-explained>EPS is
This results in the following potential growth metrics and future valuations:
Based on analysts' sales estimates for 2025, the Twist Bioscience Corp. stock is valued at an <a href=https://blog.stocksguide.com/knowledge/enterprise-value-sales-simply-explained>EV/Sales of
This results in the following potential growth metrics and future valuations:
Twist Bioscience Corp....
Current Twist Bioscience Corp. Upgrades & Downgrades Beta
| Analyst | Rating | Action | Date |
|---|---|---|---|
| Baird | Locked ➜ Locked | Locked | Feb 04 2025 |
| JP Morgan | Locked ➜ Locked | Locked | Feb 04 2025 |
| Scotiabank | Locked ➜ Locked | Locked | Feb 04 2025 |
| Wolfe Research | Locked ➜ Locked | Locked | Dec 13 2024 |
| TD Cowen | Locked ➜ Locked | Locked | Nov 26 2024 |
| Baird | Locked ➜ Locked | Locked | Nov 19 2024 |
| Barclays | Locked ➜ Locked | Locked | Nov 19 2024 |
| Analyst Rating | Date |
|---|---|
|
Locked
Baird: Locked ➜ Locked
|
Feb 04 2025 |
|
Locked
JP Morgan: Locked ➜ Locked
|
Feb 04 2025 |
|
Locked
Scotiabank: Locked ➜ Locked
|
Feb 04 2025 |
|
Locked
Wolfe Research: Locked ➜ Locked
|
Dec 13 2024 |
|
Locked
TD Cowen: Locked ➜ Locked
|
Nov 26 2024 |
|
Locked
Baird: Locked ➜ Locked
|
Nov 19 2024 |
|
Locked
Barclays: Locked ➜ Locked
|
Nov 19 2024 |
Discover more stocks with a high price target
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
